Rituximab+ Zanubrutinib for Patients With Hairy Cell Leukemia and Hairy Cell Variant

NCT07690761 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

12

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hairy Cell Leukemia
Hairy Cell Leukemia Variant

Interventions

DRUG: Zanubrutinib

Sponsor

Bnai Zion Medical Center

Collaborators

[object Object]
[object Object]